847 related articles for article (PubMed ID: 19164350)
1. Quality of life measured by the St George's Respiratory Questionnaire and spirometry.
Weatherall M; Marsh S; Shirtcliffe P; Williams M; Travers J; Beasley R
Eur Respir J; 2009 May; 33(5):1025-30. PubMed ID: 19164350
[TBL] [Abstract][Full Text] [Related]
2. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6.
Vandevoorde J; Verbanck S; Schuermans D; Kartounian J; Vincken W
Eur Respir J; 2006 Feb; 27(2):378-83. PubMed ID: 16452596
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
[TBL] [Abstract][Full Text] [Related]
5. Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.
Chen CZ; Ou CY; Wang WL; Lee CH; Lin CC; Chang HY; Hsiue TR
COPD; 2012 Jun; 9(3):276-80. PubMed ID: 22360379
[TBL] [Abstract][Full Text] [Related]
6. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care.
Schermer TR; Smeele IJ; Thoonen BP; Lucas AE; Grootens JG; van Boxem TJ; Heijdra YF; van Weel C
Eur Respir J; 2008 Oct; 32(4):945-52. PubMed ID: 18550607
[TBL] [Abstract][Full Text] [Related]
7. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of lung volume response with airflow response to bronchodilator in patients with chronic obstructive pulmonary disease].
Zhang FQ; Zheng JP; Wang JH; Lu WB; Wu RX; Li XS; Xian QZ; Gao Y; Jiang M
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):109-13. PubMed ID: 20367950
[TBL] [Abstract][Full Text] [Related]
9. [Relation between pulmonary ventilation parameters, exercise tolerance and quality of life in patients with chronic obstructive lung disease].
Chlumský J; Stĕrbová L; Smolíková L; Matous M; Salajka F
Vnitr Lek; 2002 Apr; 48(4):320-4. PubMed ID: 12061182
[TBL] [Abstract][Full Text] [Related]
10. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.
Troosters T; Celli B; Lystig T; Kesten S; Mehra S; Tashkin DP; Decramer M;
Eur Respir J; 2010 Jul; 36(1):65-73. PubMed ID: 20185426
[TBL] [Abstract][Full Text] [Related]
11. External validation of a COPD diagnostic questionnaire.
Kotz D; Nelemans P; van Schayck CP; Wesseling GJ
Eur Respir J; 2008 Feb; 31(2):298-303. PubMed ID: 17959636
[TBL] [Abstract][Full Text] [Related]
12. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
[TBL] [Abstract][Full Text] [Related]
13. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT).
Morice AH; Celli B; Kesten S; Lystig T; Tashkin D; Decramer M
Respir Med; 2010 Nov; 104(11):1659-67. PubMed ID: 20724131
[TBL] [Abstract][Full Text] [Related]
14. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of the quality of life with the inspiratory capacity in patients with chronic obstructive pulmonary disease].
Shen N; Yao WZ; Liu Z; Wang XH; Hao ZT; Liu XF
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):261-4. PubMed ID: 20646455
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion.
Berton DC; Silveira L; Da Costa CC; De Souza RM; Winter CD; Zimermann Teixeira PJ
Arch Phys Med Rehabil; 2013 Aug; 94(8):1607-14. PubMed ID: 23416765
[TBL] [Abstract][Full Text] [Related]
17. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
Hajiro T; Nishimura K; Tsukino M; Ikeda A; Oga T
Respir Med; 2000 Sep; 94(9):841-6. PubMed ID: 11001074
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.
Fukuchi Y; Fernandez L; Kuo HP; Mahayiddin A; Celli B; Decramer M; Kesten S; Liu D; Tashkin D
Respirology; 2011 Jul; 16(5):825-35. PubMed ID: 21539680
[TBL] [Abstract][Full Text] [Related]
19. Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.
Checkley W; Foreman MG; Bhatt SP; Dransfield MT; Han M; Hanania NA; Hansel NN; Regan EA; Wise RA;
Respir Med; 2016 Feb; 111():30-8. PubMed ID: 26712569
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a claims-based prediction model for COPD severity.
Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
